Tanvex BioPharma, Inc.
TWSE:6541.TW
70 (TWD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 380.752 | 786.233 | 2,222.977 | 2,068.608 | 2,427.451 | 1,630.705 | 2,010.071 | 1,301.659 | 758.225 | 203.205 | 168.517 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 1,896.58 | 1,053.033 | 1,613.787 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 380.752 | 786.233 | 2,222.977 | 2,068.608 | 2,427.451 | 1,630.705 | 3,063.104 | 2,915.446 | 758.225 | 203.205 | 168.517 |
| Net Receivables
| 10.358 | 2.758 | 2.883 | 1.909 | 1.29 | 140.46 | 1.445 | 5.17 | 0.456 | 0 | 0 |
| Inventory
| 108.285 | 170.841 | 90.331 | 50.082 | 52.203 | 28.578 | -941.457 | -1,581.167 | -0.456 | 0 | 0 |
| Other Current Assets
| 104.817 | 86.645 | 85.797 | 142.914 | 124.03 | 1,896.58 | 1,053.033 | 1,613.787 | 22.247 | 15.22 | 14.249 |
| Total Current Assets
| 604.212 | 1,043.719 | 2,401.988 | 2,263.513 | 2,604.974 | 3,696.323 | 3,176.125 | 2,953.236 | 780.472 | 218.425 | 182.766 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1,928.141 | 2,150.56 | 2,113.852 | 1,906.277 | 922.96 | 735.55 | 747.168 | 832.549 | 704.701 | 385.741 | 246.849 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 3.383 | 12.069 | 10.167 | 11.957 | 15.932 | 18.168 | 24.626 | 57.665 | 59.749 | 46.476 | 42.501 |
| Goodwill and Intangible Assets
| 3.383 | 12.069 | 10.167 | 11.957 | 15.932 | 18.168 | 24.626 | 57.665 | 59.749 | 46.476 | 42.501 |
| Long Term Investments
| 201.48 | 203.564 | 180.05 | 182.715 | 0 | 0 | 0 | 0 | 21.774 | 0 | 0 |
| Tax Assets
| 0 | -203.564 | -180.05 | -182.715 | 0 | 0 | 0 | 0 | -21.774 | 0 | 0 |
| Other Non-Current Assets
| 26.187 | 213.468 | 187.582 | 190.978 | 29.127 | 28.728 | 25.084 | 28.902 | 24.492 | 4.097 | 15.156 |
| Total Non-Current Assets
| 2,159.191 | 2,376.097 | 2,311.601 | 2,109.212 | 968.019 | 782.446 | 796.878 | 919.116 | 788.942 | 436.314 | 304.506 |
| Total Assets
| 2,763.403 | 3,419.816 | 4,713.589 | 4,372.725 | 3,572.993 | 4,478.769 | 3,973.003 | 3,872.352 | 1,569.414 | 654.739 | 487.272 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 0 | -28.069 | 0 | 0 | 0 | 0 | 159.496 | 1.934 | 99.65 | 0.538 | 0.384 |
| Short Term Debt
| 163.448 | 124.654 | 88.746 | 65.735 | 71.066 | 7.277 | 1.395 | 1.934 | 0 | 0.538 | 0.384 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.244 | 3.199 | 0 | 0 |
| Deferred Revenue
| 6.906 | 28.069 | 0 | 0 | 0 | 0 | -1.395 | 0 | 0 | 41.568 | 60.104 |
| Other Current Liabilities
| 193.376 | 178.631 | 159.768 | 287.364 | 199.382 | 202.186 | 5.208 | 229.279 | 2.752 | 2.231 | 1.715 |
| Total Current Liabilities
| 363.73 | 303.285 | 248.514 | 353.099 | 270.448 | 209.463 | 164.704 | 233.147 | 102.402 | 44.875 | 62.587 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 1,568.333 | 1,714.582 | 1,670.28 | 1,398.911 | 271.674 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 10.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -1,568.333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1,568.333 | 10.469 | 0 | 0 | 0 | 54.453 | 59.078 | 66.098 | 19.012 | 20.22 | 21.041 |
| Total Non-Current Liabilities
| 1,578.563 | 1,725.051 | 1,670.28 | 1,398.911 | 271.674 | 54.453 | 59.078 | 66.098 | 19.012 | 20.22 | 21.041 |
| Total Liabilities
| 1,942.293 | 2,028.336 | 1,918.794 | 1,752.01 | 542.122 | 263.916 | 223.782 | 299.245 | 121.414 | 65.095 | 83.628 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.967 |
| Common Stock
| 1,339.629 | 3,526.606 | 3,524.547 | 3,116.067 | 2,642.041 | 2,430.678 | 2,166.364 | 1,929.927 | 1,664.084 | 0.392 | 0.24 |
| Retained Earnings
| -12,754.94 | -12,968.566 | -11,327.436 | -9,784.225 | -7,679.989 | -5,383.363 | -3,489.501 | -2,079.701 | -835.255 | -336.708 | -72.15 |
| Accumulated Other Comprehensive Income/Loss
| 949.026 | 592.453 | 363.958 | 344.614 | 355.586 | 239.042 | 37.016 | 121.078 | 104.402 | 13.35 | -4.967 |
| Other Total Stockholders Equity
| 11,287.395 | 10,240.987 | 10,233.726 | 8,944.259 | 7,713.233 | 6,928.496 | 5,035.342 | 3,601.803 | 514.769 | 912.61 | 475.554 |
| Total Shareholders Equity
| 821.11 | 1,391.48 | 2,794.795 | 2,620.715 | 3,030.871 | 4,214.853 | 3,749.221 | 3,573.107 | 1,448 | 589.644 | 403.644 |
| Total Equity
| 821.11 | 1,391.48 | 2,794.795 | 2,620.715 | 3,030.871 | 4,214.853 | 3,749.221 | 3,573.107 | 1,448 | 589.644 | 403.644 |
| Total Liabilities & Shareholders Equity
| 2,763.403 | 3,419.816 | 4,713.589 | 4,372.725 | 3,572.993 | 4,478.769 | 3,973.003 | 3,872.352 | 1,569.414 | 654.739 | 487.272 |